Can stomach cancer surgery also tame diabetes?

NCT ID NCT04284943

First seen Aug 07, 2026 ยท Last updated Aug 07, 2026

Summary

This trial tests three different ways to reconnect the digestive tract after stomach cancer surgery to see which one best controls blood sugar in people who also have type 2 diabetes. Participants will be randomly assigned to one of three surgical procedures. The main goal is to see if any method helps achieve a normal blood sugar level (HbA1c below 6.5%) without diabetes medications.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Surgical procedure: Billroth II, conventional Roux-en-Y, or long limb Roux-en-Y reconstruction after subtotal gastrectomy
What this could lead to
If successful, this could identify a surgical approach that not only treats gastric cancer but also improves or resolves type 2 diabetes, potentially reducing the need for diabetes medications.
What could go wrong
This is a relatively small trial, and results may not apply to all patients. Surgery carries risks like infection, bleeding, or digestive issues, and the effect on diabetes may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Korea University Anam Hospital

    RECRUITING

    Seoul, 02841, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.